Reported 0 shares, down 44,832 (100.0%) from the prior quarter.
Reported value -100.0%; share count -100.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 194000 |
| 2021-12-31 | 0 |
| 2022-03-31 | 738000 |
| 2022-06-30 | 376000 |
| 2022-09-30 | 82000 |
| 2022-12-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q4 2022 | Reduced | 0 | -44,832 (-100.0%) | 0 | $0 | 2023-02-14 | |
| Q3 2022 | Reduced | 44,832 | -74,619 (-62.5%) | < 0.01% | $82,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 119,451 | 0 (0.0%) | < 0.01% | $376,000 | 2022-08-15 | |
| Q1 2022 | New | 119,451 | +119,451 (0.0%) | < 0.01% | $738,000 | 2022-05-16 | |
| Q4 2021 | Reduced | 0 | -24,303 (-100.0%) | 0 | $0 | 2022-02-14 | |
| Q3 2021 | Unchanged | 24,303 | 0 (0.0%) | < 0.01% | $194,000 | 2021-11-15 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
63 managers reported ESSA PHARMA INC for Q4 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BVF INC IL | Unchanged | 8,748,629 | 0 | 0.93% | $22,046,545 | 19 qtrs |
| Bellevue Group AG | Added | 7,898,583 | +2,000,000 | 0.26% | $19,904,429 | 8 qtrs |
| Soleus Capital Management L P | Added | 3,869,392 | +1,228,853 | 1.4% | $9,750,868 | 13 qtrs |
| PFM Health Sciences LP | Added | 3,844,332 | +2,366,080 | 0.35% | $9,687,717 | 3 qtrs |
| MORGAN STANLEY | Reduced | 2,006,477 | -98,743 | < 0.01% | $5,056,322 | 13 qtrs |
| Avidity Partners Management LP | Reduced | 1,855,400 | -604,600 | 0.1% | $4,675,608 | 10 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Unchanged | 1,042,531 | 0 | < 0.01% | $2,627,178 | 8 qtrs |
| Ally Bridge Group NY LLC | New | 811,555 | +811,555 | 1.99% | $2,045,119 | 1 qtr |
| Frazier Life Sciences Management L P | Reduced | 605,141 | -87,769 | 0.09% | $1,524,955 | 4 qtrs |
| Rock Springs Capital Management LP | Unchanged | 524,944 | 0 | 0.03% | $1,322,859 | 8 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2022
- Filed
- February 14, 2023
- Filing type
- 13F-HR
- Position type
- COMM STK
Voting authority reported
No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.